CD34+ hematopoietic stem and progenitor cells from JAK2V617F+ primary myelofibrosis enriched a larger number of inflammatory pathways and immune response signaling pathways than those from JAK2V617F+ polycythemia vera and JAK2V617F+ essential thrombocythemia. Here, CD34 is linked to acquired polycythemia vera.